The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Abstract
Summary: Venous thromboembolism (VTE) is a significant health problem in the general population but especially in cancer patients. In this review, we discuss the epidemiology and burden of the disease, the pathophysiology of cancer-associated VTE, and the clinical treatment options for both primary prevention and acute treatment. Overall, the development of VTE in cancer patients is related to increases in morbidity, mortality, and medical costs. However, the incidence of cancer-associated VTE varies due to patient-related factors (e.g. thrombophilia, comorbidities, performance status, history of venous diseases), tumour-related factors (e.g. cancer site, stage, grade), and treatment-related factors (e.g. surgery, chemotherapy, anti-angiogenesis treatment, hormonal and supportive treatment). Furthermore, blood count parameters (e.g. platelets and leukocytes) and biomarkers (e.g. soluble P-selectin and D-dimer) are predictive markers for the risk of VTE in cancer patients and have been used to enhance risk stratification. Evidence suggests that cancer itself is associated with a state of hypercoagulability, driven in part by the release of procoagulant factors, such as tissue factor, from malignant tissue as well as by inflammation-driven activation of endothelial cells, platelets, and leukocytes. In general, low-molecular-weight heparin (LWMH) monotherapy is the standard of care for the management of cancer-associated VTE, as vitamin K antagonists are less effective in cancer patients. Direct oral anticoagulants (DOACs) offer a potentially promising treatment option for cancer patients with VTE, but recommendations concerning the routine use of DOACs should await head-to-head studies with LMWH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Lee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Extracellular DNA traps promote thrombosis
Fuchs, T. A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D. D., Wrobleski, S. K., Wakefield, T. W., Hartwig, J. H., & Wagner, D. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005743107 · Cited by 2,492
Development and validation of a predictive model for chemotherapy-associated thrombosis
Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., & Francis, C. W. (2008) · Blood · doi:10.1182/blood-2007-10-116327 · Cited by 2,217
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
von Brühl, M.-L., Stark, K., Steinhart, A., Chandraratne, S., Konrad, I., Lorenz, M., Khandoga, A., Tirniceriu, A., Coletti, R., Köllnberger, M., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112322 · Cited by 1,823
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Lyman, G. H., Bohlke, K., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7351 · Cited by 1,371
Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers
Chew, H. K., Wun, T., Harvey, D. J., Zhou, H., & White, R. H. R. (2006) · Archives of Internal Medicine · doi:10.1001/.458 · Cited by 1,321
Heit, J. A., O'Fallon, W. M., Petterson, T. M., Lohse, C. M., Silverstein, M. D., Mohr, D. N., & Melton, L. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.11.1245 · Cited by 1,104
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Levitan, N., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
Demers, M., Krause, D. S., Schatzberg, D., Martinod, K., Voorhees, J. R., Fuchs, T. A., Scadden, D. T., & Wagner, D. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200419109 · Cited by 883
Thrombosis: tangled up in NETs
Martinod, K., & Wagner, D. D. (2014) · Blood · doi:10.1182/blood-2013-10-463646 · Cited by 866
Rajkumar, S. V., Blood, E., Vesole, D., Fonseca, R., & Greipp, P. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0221 · Cited by 865
van Es, N., Coppens, M., Schulman, S., Middeldorp, S., & Büller, H. R. (2014) · Blood · doi:10.1182/blood-2014-04-571232 · Cited by 851
Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007) · Cancer · doi:10.1002/cncr.23062 · Cited by 781
Prediction of venous thromboembolism in cancer patients
Ay, C., Dunkler, D., Marosi, C., Chiriac, A.-L., Vormittag, R., Simanek, R., Quehenberger, P., Zielinski, C., & Pabinger, I. (2010) · Blood · doi:10.1182/blood-2010-02-270116 · Cited by 772
Self-citationNalluri, S. R., Chu, D., Keresztes, R., Zhu, X., & Wu, S. (2008) · JAMA · doi:10.1001/jama.2008.656 · Cited by 771
Hutten, B. A., Prins, M. H., Gent, M., Ginsberg, J., Tijssen, J. G. P., & Büller, H. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3078 · Cited by 748
Lyman, G. H., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., Gates, L. E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1118 · Cited by 713
BLOM, J. W., VANDERSCHOOT, J. P. M., OOSTINDIËR, M. J., OSANTO, S., VAN DER MEER, F. J. M., & ROSENDAAL, F. R. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01804.x · Cited by 692
Agnelli, G., Bolis, G., Capussotti, L., Scarpa, R. M., Tonelli, F., Bonizzoni, E., Moia, M., Parazzini, F., Rossi, R., Sonaglia, F., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000193959.44677.48 · Cited by 690
D-dimer antigen: current concepts and future prospects
Adam, S. S., Key, N. S., & Greenberg, C. S. (2009) · Blood · doi:10.1182/blood-2008-06-165845 · Cited by 668
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
Lee, A. Y. Y., Kamphuisen, P. W., Meyer, G., Bauersachs, R., Janas, M. S., Jarner, M. F., Khorana, A. A., & for the CATCH Investigators (2015) · JAMA · doi:10.1001/jama.2015.9243 · Cited by 614
FARGE, D., DEBOURDEAU, P., BECKERS, M., BAGLIN, C., BAUERSACHS, R. M., BRENNER, B., BRILHANTE, D., FALANGA, A., GEROTZAFIAS, G. T., HAIM, N., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12070 · Cited by 595
Self-citationBernardo, A., Ball, C., Nolasco, L., Moake, J. F., & Dong, J.-F. (2004) · Blood · doi:10.1182/blood-2004-01-0107 · Cited by 588
Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis
Fuchs, T. A., Brill, A., & Wagner, D. D. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.242859 · Cited by 586
Incidence of Venous Thromboembolism in Patients Hospitalized with Cancer
Stein, P. D., Beemath, A., Meyers, F. A., Skaf, E., Sanchez, J., & Olson, R. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.058 · Cited by 566
Kireev, D., Popenko, N., Pichugin, A., Panteleev, M., Krymskaya, O., Ataullakhanov, F., & Sinauridze, E. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-06-0313 · Cited by 553
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Gomez, M. L., Gomez‐Raposo, C., & Lobo Samper, F. (2008) · Cancer · doi:10.1002/cncr.23524 · Cited by 549
Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?
TESSELAAR, M. E. T., ROMIJN, F. P. H. T. M., VAN DER LINDEN, I. K., PRINS, F. A., BERTINA, R. M., & OSANTO, S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02369.x · Cited by 548
van der Hulle, T., Kooiman, J., den Exter, P. L., Dekkers, O. M., Klok, F. A., & Huisman, M. V. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12485 · Cited by 536
Gupta, A. K., Joshi, M. B., Philippova, M., Erne, P., Hasler, P., Hahn, S., & Resink, T. J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.006 · Cited by 534
Walker, A. J., Card, T. R., West, J., Crooks, C., & Grainge, M. J. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.021 · Cited by 512
Khorana, A. A., Dalal, M., Lin, J., & Connolly, G. C. (2013) · Cancer · doi:10.1002/cncr.27772 · Cited by 480
Zwicker, J. I., Liebman, H. A., Neuberg, D., Lacroix, R., Bauer, K. A., Furie, B. C., & Furie, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0371 · Cited by 479
Thromboembolism in Hospitalized Neutropenic Cancer Patients
Khorana, A. A., Francis, C. W., Culakova, E., Fisher, R. I., Kuderer, N. M., & Lyman, G. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8877 · Cited by 475
Ay, C., Simanek, R., Vormittag, R., Dunkler, D., Alguel, G., Koder, S., Kornek, G., Marosi, C., Wagner, O., Zielinski, C., et al. (2008) · Blood · doi:10.1182/blood-2008-02-142422 · Cited by 422
Self-citationAy, C., Vormittag, R., Dunkler, D., Simanek, R., Chiriac, A.-L., Drach, J., Quehenberger, P., Wagner, O., Zielinski, C., & Pabinger, I. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7752 · Cited by 422
Self-citationCellular microparticles: what are they bad or good for?
Freyssinet, J.-M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00309.x · Cited by 399
Deitcher, S. R., Kessler, C. M., Merli, G., Rigas, J. R., Lyons, R. M., & Fareed, J. (2006) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029606293692 · Cited by 392
Cronin-Fenton, D. P., Søndergaard, F., Pedersen, L. A., Fryzek, J. P., Cetin, K., Acquavella, J., Baron, J. A., & Sørensen, H. T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605883 · Cited by 372
Venous Thromboembolism in Patients With Colorectal Cancer: Incidence and Effect on Survival
Alcalay, A., Wun, T., Khatri, V., Chew, H. K., Harvey, D., Zhou, H., & White, R. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2150 · Cited by 365
Szotowski, B., Antoniak, S., Poller, W., Schultheiss, H.-P., & Rauch, U. (2005) · Circulation Research · doi:10.1161/01.res.0000171805.24799.fa · Cited by 293
Prins, M. H., Lensing, A. W. A., Brighton, T. A., Lyons, R. M., Rehm, J., Trajanovic, M., Davidson, B. L., Beyer-Westendorf, J., Pap, Á. F., Berkowitz, S. D., et al. (2014) · The Lancet Haematology · doi:10.1016/s2352-3026(14)70018-3 · Cited by 283
Self-citationIncidence of Venous Thromboembolism and the Impact on Survival in Breast Cancer Patients
Chew, H. K., Wun, T., Harvey, D. J., Zhou, H., & White, R. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.4393 · Cited by 278
THALER, J., AY, C., MACKMAN, N., BERTINA, R. M., KAIDER, A., MAROSI, C., KEY, N. S., BARCEL, D. A., SCHEITHAUER, W., KORNEK, G., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04754.x · Cited by 274
Self-citationHolm, T., Singnomklao, T., Rutqvist, L.-E., & Cedermark, B. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960901)78:5<968::aid-cncr5>3.0.co;2-8 · Cited by 274
Teitel, J., Bauer, K., Lau, H., & Rosenberg, R. (1982) · Blood · doi:10.1182/blood.v59.5.1086.1086 · Cited by 264
SIMANEK, R., VORMITTAG, R., AY, C., ALGUEL, G., DUNKLER, D., SCHWARZINGER, I., STEGER, G., JAEGER, U., ZIELINSKI, C., & PABINGER, I. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03680.x · Cited by 249
Self-citationSeng, S., Liu, Z., Chiu, S. K., Proverbs-Singh, T., Sonpavde, G., Choueiri, T. K., Tsao, C.-K., Yu, M., Hahn, N. M., Oh, W. K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.4358 · Cited by 246
Ueno, T., Toi, M., Koike, M., Nakamura, S., & Tominaga, T. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1272 · Cited by 243
Endothelial cell activation: A central pathophysiological process
Hunt, B. J., & Jurd, K. M. (1998) · BMJ · doi:10.1136/bmj.316.7141.1328 · Cited by 241
Incidence of Venous Thromboembolism in the Year Before the Diagnosis of Cancer in 528 693 Adults
White, R. H., Chew, H. K., Zhou, H., Parikh-Patel, A., Harris, D., Harvey, D., & Wun, T. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1782 · Cited by 231
Chen, M., & Geng, J.-G. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0010-6 · Cited by 226
Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles
Binder, B. R., Christ, G., Gruber, F., Grubic, N., Hufnagl, P., Krebs, M., Mihaly, J., & Prager, G. W. (2002) · Physiology · doi:10.1152/nips.01369.2001 · Cited by 225
Venous thromboembolism: Epidemiology and magnitude of the problem
Goldhaber, S. Z. (2012) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2012.06.007 · Cited by 222
Posch, F., Königsbrügge, O., Zielinski, C., Pabinger, I., & Ay, C. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.07.011 · Cited by 215
Self-citationRisk factors for venous thromboembolic events in cancer patients
Kröger, K., Weiland, D., Ose, C., Neumann, N., Weiss, S., Hirsch, C., Urbanski, K., Seeber, S., & Scheulen, M. E. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj068 · Cited by 212
Gussoni, G., Frasson, S., La Regina, M., Di Micco, P., & Monreal, M. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2012.10.007 · Cited by 209
New Oral Anticoagulants and the Cancer Patient
Short, N. J., & Connors, J. M. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0239 · Cited by 204
Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score
Zakai, N. A., Wright, J., & Cushman, M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00991.x · Cited by 202
Agnelli, G., Buller, H. R., Cohen, A., Gallus, A. S., Lee, T. C., Pak, R., Raskob, G. E., Weitz, J. I., & Yamabe, T. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13153 · Cited by 197
Self-citationIncreased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
Manly, D. A., Wang, J., Glover, S. L., Kasthuri, R., Liebman, H. A., Key, N. S., & Mackman, N. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.09.019 · Cited by 194
Adam, S. S., McDuffie, J. R., Ortel, T. L., & Williams, J. W. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00532 · Cited by 194
Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis
Lyman, G. H., Eckert, L., Wang, Y., Wang, H., & Cohen, A. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0226 · Cited by 194
Self-citationCancer, Clots and Consensus: New Understanding of an Old Problem
Lyman, G. H., & Khorana, A. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3032 · Cited by 190
LEVINE, M. N., GU, C., LIEBMAN, H. A., ESCALANTE, C. P., SOLYMOSS, S., DEITCHMAN, D., RAMIREZ, L., & JULIAN, J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04693.x · Cited by 190
Guideline on aspects of cancer‐related venous thrombosis
Watson, H. G., Keeling, D. M., Laffan, M., Tait, R. C., & Makris, M. (2015) · British Journal of Haematology · doi:10.1111/bjh.13556 · Cited by 182
Venous Thromboembolism After Major Cancer Surgery: Temporal Trends and Patterns of Care
Trinh, V. Q., Karakiewicz, P. I., Sammon, J., Sun, M., Sukumar, S., Gervais, M.-K., Shariat, S. F., Tian, Z., Kim, S. P., Kowalczyk, K. J., et al. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.3172 · Cited by 182
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
Uno, K., Homma, S., Satoh, T., Nakanishi, K., Abe, D., Matsumoto, K., Oki, A., Tsunoda, H., Yamaguchi, I., Nagasawa, T., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603552 · Cited by 177
Raskob, G. E., van Es, N., Segers, A. E. M., Angchaisuksiri, P., Oh, D., Boda, Z., Lyons, R. M., Meijer, K., Gudz, I., Weitz, J. I., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30057-6 · Cited by 167
Malignancy, thrombosis and Trousseau: the case for an eponym
Khorana, A. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.00501.x · Cited by 166
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
Goldhaber, S. Z., Kearon, C., Kakkar, A. K., Schellong, S., Eriksson, H., Hantel, S., Feuring, M., Kreuzer, J., & Schulman, S. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-11-0977 · Cited by 159
The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis
Nickel, K. F., Ronquist, G. K., Länger, F. P., Labberton, L., Fuchs, T. A., Bokemeyer, C., Sauter, G., Graefen, M., Mackman, N., Stavrou, E. X., et al. (2015) · Blood · doi:10.1182/blood-2015-01-622811 · Cited by 155
Kirchhofer, D., Tschopp, T., Hadváry, P., & Baumgartner, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117202 · Cited by 155
Pyke, C., Kristensen, P. K., Ralfkiaer, E. M., Eriksen, J., & Danø, K. (1991) · PubMed · Cited by 143
Zwicker, J. I., Liebman, H. A., Bauer, K. A., Caughey, T., Campigotto, F., Rosovsky, R. P. G., Mantha, S. H., Kessler, C. M., Eneman, J. D., Raghavan, V. R., et al. (2012) · British Journal of Haematology · doi:10.1111/bjh.12163 · Cited by 142
Ahlbrecht, J., Dickmann, B., Ay, C., Dunkler, D., Thaler, J., Schmidinger, M., Quehenberger, P., Haitel, A., Zielinski, C. C., & Pabinger, I. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.1810 · Cited by 140
Self-citationMinnema, M. C., Fijnheer, R., de Groot, P. G., & Lokhorst, H. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00083.x · Cited by 119
Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer
Connolly, G. C., Dalal, M. R., Lin, J., & Khorana, A. A. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.09.007 · Cited by 118
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
Auwerda, J. J. A., Yuana, Y., Osanto, S., de Maat, M. P. M., Sonneveld, P., Bertina, R. M., & Leebeek, F. W. G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-03-0187 · Cited by 113
Romera, A., Cairols, M. A., Vila-Coll, R., Martí-Mestre, X., Colomé, E., Bonell-Pascual, A., & Lapiedra, O. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2008.11.030 · Cited by 105
Mandalà, M., Barni, S., Prins, M. H., Labianca, R., Tondini, C. A., Russo, L., Milesi, A., Cremonesi, M., Zaccanelli, M., Regonesi, C., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp354 · Cited by 99
Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma
Auwerda, J. J. A., Sonneveld, P., de Maat, M. P. M., & Leebeek, F. W. G. (2007) · Haematologica · doi:10.3324/haematol.10454 · Cited by 96
Dickmann, B., Ahlbrecht, J., Ay, C., Dunkler, D., Thaler, J., Scheithauer, W., Quehenberger, P., Zielinski, C. C., & Pabinger, I. (2013) · Haematologica · doi:10.3324/haematol.2012.073338 · Cited by 87
Self-citationNisio, M. D., Bleker, S. M., Segers, A. E. M., Mercuri, M. F., Schwocho, L. R., Kakkar, A. K., Weitz, J. I., Beyer‐Westendorf, J., Boda, Z., Carrier, M., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-06-0452 · Cited by 83
Self-citationSelf-Managed Long-Term Low-Molecular-Weight Heparin Therapy: The Balance of Benefits and Harms
Hull, R. D., Pineo, G. F., Brant, R., Mah, A. F., Burke, N., Dear, R., Wong, T., Cook, R., Solymoss, S., Poon, M., et al. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.030 · Cited by 82
Luk, C., Wells, P. S., Anderson, D. R., & Kovacs, M. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00840-3 · Cited by 78
Pabinger, I., Ay, C., Dunkler, D., Thaler, J., Reitter, E. ‐., Marosi, C., Zielinski, C. C., & Mannhalter, C. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12778 · Cited by 73
Self-citationPrevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH
Khorana, A. A., Otten, H.-M., Zwicker, J. I., Connolly, G. C., Farge, D., & Pabinger, I. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12725 · Cited by 69
Self-citationGarber, J. E., Halabi, S., Tolaney, S. M., Kaplan, E., Archer, L. E., Atkins, J. N., Edge, S., Shapiro, C. L., Dressler, L. G., Paskett, E. M., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq211 · Cited by 68
The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review
Kourlaba, G., Relakis, J., Mylonas, C., Kapaki, V., Kontodimas, S., Holm, M. V., & Maniadakis, N. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000193 · Cited by 64
Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment
Reitter, E. ‐., Kaider, A., Ay, C., Quehenberger, P., Marosi, C., Zielinski, C. C., & Pabinger, I. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13218 · Cited by 63
Self-citationJoint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism
Gran, O. V., Smith, E. N., Brækkan, S. K., Jensvoll, H., Solomon, T., Hindberg, K., Wilsgaard, T., Rosendaal, F. R., Frazer, K. A., & Hansen, J. (2016) · Haematologica · doi:10.3324/haematol.2016.147405 · Cited by 55
Delate, T., Witt, D. M., Ritzwoller, D. P., Weeks, J. C., Kushi, L. H., Hornbrook, M. C., Bowles, E. J. A., & Schrag, D. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0323 · Cited by 50
Wittkowsky, A. K. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02073.x · Cited by 49
Kyrle, P. A., & Eichinger, S. (2009) · Blood · doi:10.1182/blood-2009-05-223511 · Cited by 44
Lee, Y., Lee, E., Kim, I., Lee, K., Kim, T. M., Lee, S., Kim, D., & Heo, D. S. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2014.045 · Cited by 43
Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Mahé, I., Sterpu, R., Bertoletti, L., López‐Jiménez, L., Mellado, M., Trujillo‐Santos, J., Ballaz, A., Blasco, L., Marchena, P. J., Monréal, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128741 · Cited by 42
Cohoon, K. P., Ransom, J. E., Leibson, C. L., Ashrani, A. A., Petterson, T. M., Long, K. H., Bailey, K. R., & Heit, J. A. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.02.030 · Cited by 36
Kovac, M. K., Kovac, Z., Tomasevic, Z. I., Vučićević, S., Djordjevic, V. J., Pruner, I., & Radojkovic, D. P. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.12.015 · Cited by 34
Zöller, B., Palmér, K., Li, X., Sundquist, J., & Sundquist, K. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.07.004 · Cited by 17
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Metadata
- Authors
- Ay, C., Pabinger, I., & Cohen, A. T.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2017
- Volume
- 117
- Issue
- 02
- Pages
- 219-230
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2551096297
- Cited by
- 496
- References
- 111
- FWCI
- 22.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.